Post Vaccine Syndrome Test: What Exists and What Doesn't
Short answer
There is no validated post vaccine syndrome test. Post-vaccination syndrome has no agreed case definition, and no blood test, scan or biomarker can confirm it. Doctors work from your history and rule out other conditions. Tests that do exist apply to recognized vaccine side effects such as myocarditis and VITT, and to overlapping conditions such as POTS.

Key takeaways
- 1No validated test or agreed case definition exists for post-vaccination syndrome, so diagnosis rests on history and on excluding other causes.
- 2Published studies of people who report it are small, and several are preprints: 42 cases against 22 controls in the Yale immune profiling work.
- 3Views differ in emphasis: the German Paul-Ehrlich-Institut found no risk signal for any specific vaccine product in its 2023 review of reports, while a Yale release calls the condition unrecognized by medical authorities and little understood.
- 4Myocarditis and vaccine-induced immune thrombocytopenia and thrombosis (VITT) have defined tests, which is the difference from post-vaccination syndrome.
- 5Anyone can report a suspected side effect to VAERS, the Yellow Card scheme or the German national reporting site.
There is no validated post vaccine syndrome test. No blood test, scan or biomarker can confirm post-vaccination syndrome (PVS) today, and the condition has no agreed case definition. This guide is for anyone with long-lasting symptoms after vaccination who wants to know what doctors check, what researchers have measured, and which tests apply to which problem.
How is post-vaccination syndrome diagnosed?
It isn't, in the formal sense, because no accepted diagnostic criteria exist. In practice a clinician takes a detailed history, notes when symptoms began relative to each dose, examines you and tests for other explanations. This is the same approach used for long COVID, where the CDC says no laboratory test can definitively diagnose or rule out the condition. Our guide to the symptoms of post-vaccination syndrome lists what people report.
A specific condition found along the way can be diagnosed on its own terms. Postural orthostatic tachycardia syndrome (POTS) is one example: in adults it needs a sustained heart rate rise of at least 30 beats per minute within 10 minutes of standing (40 for ages 12 to 19), per consensus criteria summarized in CMAJ, including the Canadian Cardiovascular Society's. That result diagnoses POTS, not PVS.
What do regulators say about it?
The German regulator and Yale researchers differ in emphasis. The Paul-Ehrlich-Institut (PEI) stated in a page last updated 29 June 2023 that "Post-Vac" is not a medically defined disease and has no clear case definition for reporting. By 19 May 2023 it had received 1,547 suspected-case reports in Germany describing long COVID-like symptoms, ME/CFS, POTS or "Post-Vac", a reporting rate of 0.73 per 100,000 of more than 192 million doses. It found no risk signal for a specific vaccine product and no medically plausible indication of a direct causal link, while noting that reports aren't proven reactions.
A Yale news release on the researchers' work describes the condition as unrecognized by medical authorities and little understood. The researchers call their own findings early, and co-senior author Akiko Iwasaki said they are "far from a final answer." Both statements can be true: a safety regulator found no signal in its reports, and a research group sees a patient population that needs study.
What have researchers measured in people who report it?
Mostly symptoms and small immune or protein studies. Here is each study with its type and size.
| Study | Type and size | What it found |
|---|---|---|
| Krumholz et al., 2023 (Yale LISTEN) | Preprint, symptom survey of 241 self-reported cases | Median onset 3 days after vaccination; exercise intolerance (71%), fatigue (69%), numbness, brain fog and neuropathy (63% each) |
| Krumholz et al., 2025 | Preprint, 241 PVS vs 441 long COVID | Distinct symptom profiles; burning sensations, neuropathy and numbness more common in PVS |
| Bhattacharjee et al., 2025 | Preprint, 42 cases vs 22 controls | Immune profile differences, more Epstein-Barr virus reactivation, higher circulating spike protein; authors call it small and early |
| Arlt et al., 2024 | Peer reviewed, 50 patients with nerve symptoms vs 35 vaccinated controls | Autoantibodies to nerve structures in 9 of 50 (18%) vs 1 of 35 (3%) |
| Hanc et al., 2025 | Peer reviewed, 70 PVS vs 723 post-COVID patients, one German centre | Cognitive, depression and fatigue patterns in PVS closely resembled post-COVID |
| Waters et al., 2026 | Peer reviewed, 14 cases vs 16 controls | Altered coagulation and immune proteins in microclot deposits |
Three points stand out. Several of these are preprints that haven't been peer reviewed. Most use self-selected participants, and the Yale cohort was recruited online. And we found no study that has produced a test with a defined cutoff that tells PVS apart from other conditions. For the spike and microclot work in more detail, see our reviews of post-vaccination microclots and spike protein persistence testing.
Which vaccine side effects do have diagnostic tests?
Two are well defined, and they show what a validated work-up looks like.
For myocarditis after mRNA vaccines, archived CDC clinical guidance (last reviewed October 2023) tells clinicians to consider an electrocardiogram (ECG), a troponin level and inflammatory markers for initial evaluation, and says myocarditis is unlikely when all three are normal. CDC has published case definitions, and it states that evidence supports a causal association with mRNA vaccines. Cases were most often seen in adolescent and young adult males within 7 days of a second dose.
For thrombosis with thrombocytopenia syndrome (TTS) after adenovirus-vector vaccines, the WHO describes testing for platelet count and D-dimer plus an anti-PF4 antibody ELISA. VITT is the label when platelet-activating anti-PF4 antibodies are found and no other cause exists. The WHO gives a cumulative TTS incidence of 0.5 to 6.8 per 100,000 vaccinees, mostly 3 to 30 days after vaccination.
Chest pain, severe breathlessness, a swollen painful leg, sudden weakness on one side or a severe unusual headache could signal a heart or clot problem. Call emergency services.
Next step
Want observational data to bring to your clinician?
Our at-home amyloid fibrin test is a microscopy report, not a diagnosis, and it doesn't measure spike protein.
Which tests help, and which don't?
| Test | What it measures | Role in post-vaccination complaints | Validated for PVS? |
|---|---|---|---|
| Routine bloods | Blood counts, thyroid, kidney, liver, inflammation | Rule out other causes; can be normal | No |
| D-dimer | Fibrin breakdown fragments | Screens for clots; can be normal despite microclots, see D-dimer vs microclot testing | No |
| Troponin and ECG | Heart muscle injury and rhythm | Diagnose myocarditis | Not for PVS; yes for myocarditis |
| Anti-PF4 antibodies | Platelet-activating antibodies | Diagnose VITT after adenovirus-vector vaccines | Not for PVS |
| Spike antibody | Immune memory of vaccination or infection | Doesn't show spike in the body; PVS group had lower titers, mainly from fewer doses | No |
| Commercial autoantibody panels | Antibodies against nerve or receptor targets | Nerve autoantibodies in 18% vs 3% in one small study; we found no guideline endorsing them for PVS | No |
| Autonomic testing, tilt table | Heart rate and blood pressure on standing | Diagnoses POTS or orthostatic hypotension | Not for PVS |
| Research immune profiling | T cells, antibodies, EBV markers, spike | Experimental, small cohorts | No |
| ThT microclot microscopy | Amyloid-positive fibrin particles | Research finding, no reference range; see how to test for microclots | No |
For the difference between spike antibody and antigen assays, see our spike protein test guide. For blood work in long COVID, see our overview of the long COVID blood test.
How do you report a suspected side effect?
Reporting is separate from diagnosis. It feeds safety monitoring and doesn't prove the vaccine caused your symptoms.
- United States: report to VAERS. Anyone can report, and VAERS asks for vaccine details, symptom onset date and any lab results.
- United Kingdom: use the Yellow Card scheme run by the MHRA. Anyone can report, but it can't give medical advice.
- Germany: use nebenwirkungen.bund.de, which sends the report to the Paul-Ehrlich-Institut or BfArM. It asks for the vaccine's batch number, and it can't give individual advice.
What can you do, and what should you ask your doctor?
Keep a dated record of the vaccine product, batch number, dose dates and when each symptom started. A clinician can use that timeline, and a reporting form asks for it.
Questions to ask your doctor:
- Which other conditions could explain my symptoms, and which tests rule them out?
- Should I have an ECG or troponin test, given my chest symptoms?
- Would a standing heart rate test for POTS make sense for me?
- Could a post-COVID clinic, neurologist or cardiologist help with a specific symptom?
- What would a spike or microclot result change in my care, if anything?
- Should we file a side effect report together?
Whether to start, stop or combine any medicine or supplement is a decision for you and your clinician.
Where an at-home test fits
Our at-home amyloid test is a finger-prick dried blood sample, stained with Thioflavin T and imaged at a partner laboratory in Mexico City. The Videographic Microscopy Report counts the glowing shapes and measures their size. It is not a diagnosis, not a post-vaccination syndrome test, and it does not measure spike protein.
It also hasn't been validated against the venous platelet-poor-plasma method used in the research above, and nothing promises that a result changes your care. If you want observational data to share with a clinician, see the at-home microclot test and our amyloid fibrin test guide.
Frequently asked questions
Is there a test for post vaccine syndrome?
No. No blood test, imaging scan or biomarker has been validated to diagnose post-vaccination syndrome, and it has no agreed case definition. Clinicians take a history, examine you and test for other causes. Research groups are measuring immune markers and spike protein, but those assays are experimental and not approved as diagnostic tests.
How is post-vaccination syndrome diagnosed?
It isn't formally diagnosed, because it has no accepted criteria. A clinician records your symptoms, their timing after vaccination and your medical history, then rules out other causes. If a specific condition turns up, such as POTS or myocarditis, that condition can be diagnosed with its own tests and treated.
Can a blood test show post-vaccination syndrome?
Not on current evidence. For long COVID, the closest comparison, the CDC says no lab test can diagnose or rule it out and that lab findings shouldn't be the only measure of how a patient is doing. Blood tests are still useful for finding other treatable causes of your symptoms.
Does a spike protein test diagnose post-vaccination syndrome?
No. A spike antibody test shows immune memory from vaccination or infection. A spike antigen test is a research assay. In the 2025 Yale preprint, some people with the syndrome had detectable spike and others didn't, so neither result can confirm or exclude it.
Where do I report a suspected vaccine side effect?
In the US, report to VAERS; in the UK, to the MHRA Yellow Card scheme; in Germany, through nebenwirkungen.bund.de, which sends reports to the Paul-Ehrlich-Institut. Anyone can report. A report records a suspicion for safety monitoring, doesn't prove the vaccine caused it, and doesn't replace seeing a doctor.
Sources
- Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization. medRxiv (preprint), 2023
- Comparative Analysis of Long COVID and Post-Vaccination Syndrome: A Cross-Sectional Study of Clinical Symptoms and Machine Learning-Based Differentiation. medRxiv (preprint), 2025
- Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination. medRxiv (preprint), 2025
- High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome. Frontiers in Immunology, 2024
- Cognitive impairment, depression, and fatigue in post-COVID and post-vaccination syndrome: a large-scale cross-sectional study. European Archives of Psychiatry and Clinical Neuroscience, 2025
- Proteomic signatures of COVID-19 Post-Vaccination/Post-Infection Syndrome (PV/PIS): insights into immune dysregulation and coagulopathy. Frontiers in Cellular and Infection Microbiology, 2026
- Stellungnahme des Paul-Ehrlich-Instituts zum Thema Post-Vac-Syndrom nach COVID-19-Impfung. Paul-Ehrlich-Institut, 2023
- Immune markers of post-vaccination syndrome indicate future research directions. Yale News, 2025
- Clinical Considerations: Myocarditis after COVID-19 Vaccines. Centers for Disease Control and Prevention (archived page, last reviewed October 2023), 2023
- Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19). World Health Organization, 2023
- Long COVID Clinical Guidance. Centers for Disease Control and Prevention, 2026
- Diagnosis and management of postural orthostatic tachycardia syndrome. Canadian Medical Association Journal, 2022
- VAERS: Report an Adverse Event. CDC and FDA, 2026
- Yellow Card: reporting suspected side effects. MHRA, 2026
- Nebenwirkungen melden. BfArM and Paul-Ehrlich-Institut, 2026
At-Home Amyloid Test
Want observational data to bring to your clinician?
Our at-home amyloid fibrin test is a microscopy report, not a diagnosis, and it doesn't measure spike protein.
Next steps
- Post-Vaccination Syndrome: Symptoms, Duration and the Spike ResearchPost-vaccination syndrome (post-vaccine syndrome, PVS): symptoms, how long it lasts, and what spike persistence and microclot studies show about the cause.
- Microclots and the COVID Vaccine: What the Spike-Fibrin Research ShowsMicroclots and the COVID vaccine: what spike-fibrin lab studies and a 2026 cohort of 14 people show, and where the evidence stops today.
- Amyloid Fibrin Test: How Fibrin Amyloid Microclots Are DetectedWhat an amyloid fibrin test is, how Thioflavin T microscopy spots fibrin amyloid microclots, how it differs from D-dimer, and what it can't tell you.

Tim Ottowitz
Founder & Research Lead
Tim Ottowitz founded Amyloid Test and writes its Science Hub, turning fibrin amyloid and spike protein research into plain-language guides that stay close to the published evidence.
Keep reading

COVID Vaccine Harms: What the 2025 JPandS Review Argues
A plain-language walkthrough of the 2025 JPandS review on COVID vaccine harms: what it claims, which sources hold up, and where the evidence is weak.

Spike Protein Antibody vs Antigen Testing: What Each One Measures
Spike antibody tests measure immune memory, not spike protein. What antigen testing adds, why detox protocols stall, and what a serious panel includes.

How Long Does Spike Protein Stay in Your Body? What Studies Found
How long does spike protein stay in your body? A study-by-study timeline after infection and vaccination, with sample sizes, methods and limits.